Kendall Capital Management

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1731372 ROCKVILLE, MD

Position in ANIP

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$612,158

New position

Shares Held

7,395

first reported quarter

Ownership

0.032%

of shares outstanding

% of Portfolio

0.15%

of 13F equity value

Holder Rank

#162

of 303 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $9,113,830 across 5 Drug Manufacturers - Specialty & Generic names. ANIP ranks #4 (6.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	217,370	$3,451,835
2	UTHR	UNITED THERAPEUTICS Corp	5,881	$3,186,502
3	COLL	Collegium Pharmaceutical, Inc	34,730	$1,257,226
4	ANIP	Ani Pharmaceuticals Inc This page	7,395	$612,158
5	AMRX	Amneal Pharmaceuticals, Inc.	35,015	$606,109

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$612,158	7,395	—	Shares	Sole	2026-08-12
No filing history on record for this holder in this stock.